CEP: Career Enhancement Program

CEP：职业提升计划

• 批准号: 10713059
• 负责人: FRANCESMARY MODUGNO
• 金额: $ 7.39万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-01 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10713059
• 关键词: Advocate; Applications Grants; Award; Basic Science; Bioinformatics; Biological Models; Biometry; Cancer Center; Cancer Research Project; Career Mobility; Clinic; Clinical; Clinical Investigator; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Communities; Dedications; Department chair; Detection; Development; Disabled Persons; Discipline of obstetrics; Disease; Ensure; Environment; Epidemiology; Equilibrium; Ethnic Population; Extramural Activities; Faculty; Feedback; Fostering; Funding; Future; Generations; Goals; Group Meetings; Growth; Gynecology; Hematology; Home; Human; Individual; Institution; Investments; Joints; Leadership; Malignant Neoplasms; Malignant neoplasm of ovary; Medicine; Mentors; Minority-Serving Institution; Mission; Morehouse School of Medicine; Nursing Faculty; Oncology; Ovarian; Patients; Peer Review; Performance; Population Sciences; Positioning Attribute; Postdoctoral Fellow; Preparation; Prevention; Procedures; Process; Program Development; Puerto Rico; Reproductive Sciences; Research; Research Institute; Research Personnel; Research Project Grants; Research Training; Resources; Science; Scientist; Series; Services; Specimen; Structure; System; Target Populations; Tissues; Training; Translational Research; Translations; Underrepresented Minority; Underrepresented Populations; United States National Institutes of Health; Universities; Woman; anticancer research; cancer care; career; career development; design; experience; improved; insight; meetings; member; mid-career faculty; next generation; outreach; professor; programs; racial population; recruit; success; translational cancer research; translational impact; translational scientist; working group; Advocate; Applications Grants; Award; Basic Science; Bioinformatics; Biological Models; Biometry; Cancer Center; Cancer Research Project; Career Mobility; Clinic; Clinical; Clinical Investigator; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Communities; Dedications; Department chair; Detection; Development; Disabled Persons; Discipline of obstetrics; Disease; Ensure; Environment; Epidemiology; Equilibrium; Ethnic Population; Extramural Activities; Faculty; Feedback; Fostering; Funding; Future; Generations; Goals; Group Meetings; Growth; Gynecology; Hematology; Home; Human; Individual; Institution; Investments; Joints; Leadership; Malignant Neoplasms; Malignant neoplasm of ovary; Medicine; Mentors; Minority-Serving Institution; Mission; Morehouse School of Medicine; Nursing Faculty; Oncology; Ovarian; Patients; Peer Review; Performance; Population Sciences; Positioning Attribute; Postdoctoral Fellow; Preparation; Prevention; Procedures; Process; Program Development; Puerto Rico; Reproductive Sciences; Research; Research Institute; Research Personnel; Research Project Grants; Research Training; Resources; Science; Scientist; Series; Services; Specimen; Structure; System; Target Populations; Tissues; Training; Translational Research; Translations; Underrepresented Minority; Underrepresented Populations; United States National Institutes of Health; Universities; Woman; anticancer research; cancer care; career; career development; design; experience; improved; insight; meetings; member; mid-career faculty; next generation; outreach; professor; programs; racial population; recruit; success; translational cancer research; translational impact; translational scientist; working group

PROJECT SUMMARY – CAREER ENHANCEMENT PROGRAM (CEP) The mission of the Hillman Cancer Center (HCC) Ovarian Cancer (OvCa) SPORE Career Enhancement Program (CEP) is to foster the development of independent translational ovarian cancer researchers who will impact ovarian cancer care. This includes supporting not only outstanding early career scientists, but also experienced investigators wishing to transition their careers into translational ovarian cancer research, or clinical investigators well versed in the design and performance of clinical trials who wish to broaden their translational research experience. The HCC OvCa SPORE is fully committed to diversity and has established collaborations with external institutions to increase the participation of under-represented scientists in the CEP. The CEP will provide funding, access to SPORE resources, and a supportive research environment. Proposals will be solicited annually and use an NIH-style peer-review scoring system to prioritize projects for funding. Projects will be funded for 2 years at $50,000 per year, with half the monies coming from CEP and the other half from institutional funds. The second year of funding will be contingent on progress made during the first year. The CEP Co-Directors, SPORE Executive Committee, and SPORE investigators will participate in the review process, together with Patient Advocates and ad hoc expert revewers when necessary. The final selection of awardees will be made following a second tier review involving the SPORE Internal Advisory Board (IAB). CEP awardees will be matched with an appropriate SPORE mentor and provided full access to the HCC OvCa SPORE Core resources, including tissue specimens and bioinformatics/biostatistical support. The CEP will directly facilitate career development through: i) constructive proposal review and feedback; ii) research training with a mentor chosen from among diverse faculty with broad expertise and experience in academic career development; and iii) access to development programs, including monthly ovarian cancer research group meetings, monthly SPORE meetings, the annual HCC and Magee Womens Research Institute retreats, and the annual SPORE retreat. The CEP will track progress of awardees and ensure that they obtain any needed services from SPORE Cores, and make certain that they are fully integrated into the SPORE program. Awardees will meet regularly with mentors and will be encouraged to participate in courses in clinical and translational research to further enhance their career development. Projects that show the greatest likelihood of impact and translation to the clinic can evolve into future full SPORE projects. Awardees will also be advised as appropriate in the preparation of grant applications for funding outside the SPORE mechanism and given access to SPORE resources to aid in this endeavor. These procedures were developed via a previous joint P50 award that resulted in a 12-fold return on investment for CEP projects. Ultimately, the CEP provides a vital mechanism for achieving the SPORE’s goal of developing the next generation of ovarian cancer researchers committed to overcoming this deadly disease.

项目摘要 - 职业增强计划（CEP） 希尔曼癌症中心（HCC）卵巢癌（OVCA）孢子职业生涯增强的任务 计划（CEP）是为了促进独立翻译的卵巢癌研究人员的发展 影响卵巢癌护理。这不仅包括支持杰出的早期职业科学家，还包括支持 希望将职业转变为转化卵巢癌研究的经验丰富的调查人员或 临床研究人员精通临床试验的设计和性能，他们希望扩大其 翻译研究经验。 HCC OVCA孢子完全致力于多样性，并已建立 与外部机构的合作，以增加代表性不足的科学家参与CEP的参与。 CEP将提供资金，获得孢子资源以及支持的研究环境。建议 每年都会征集并使用NIH风格的同行评估评分系统来优先考虑资金项目。 项目将以每年50,000美元的价格资助2年，其中一半的资金来自CEP，另一款来自CEP 一半来自机构资金。资金的第二年将取决于第一次的进度 年。 CEP联合导演，孢子执行委员会和孢子调查人员将参加 审查过程，与患者的拥护者和临时专家一起在必要时揭示。决赛 涉及孢子内部咨询的第二层审查后，将选择获奖者 董事会（IAB）。 CEP获奖者将与适当的孢子精神匹配，并为 HCC OVCA孢子核心资源，包括组织标本和生物信息学/生物统计学支持。 CEP将通过以下方式直接促进职业发展：i）建设性提案审查和反馈； ii） 研究培训具有从潜水员教师中的心理选择，具有广泛的专业知识和经验 学术职业发展； iii）进入开发计划，包括每月卵巢癌 研究小组会议，每月孢子会议，年度HCC和Magee Womens Research Institute 务虚会和年度孢子静修。 CEP将跟踪获奖者的进度，并确保他们获得 孢子核心所需的任何服务，并确保它们已完全集成到孢子中 程序。获奖者将定期与导师会面，并鼓励参加临床课程 并翻译研究以进一步增强其职业发展。显示最大的项目 影响和转化为诊所的可能性可能会演变为未来的完整孢子项目。获奖者也将 在准备资助孢子机制之外的资金申请中适当建议 并可以访问孢子资源以帮助这项工作。这些程序是通过 先前的联合P50奖给CEP项目带来了12倍的投资回报。最终，CEP 提供了实现孢子发展下一代卵巢的目标的重要机制 癌症研究人员致力于克服这种致命的疾病。